About Geistlich Pharma
Geistlich Pharma is a Healthcare company based in Wolhusen (Switzerland) founded in 1851. Geistlich Pharma is engaged in regenerative biomaterials for dental and orthopedic applications. It operates on a Direct-to-Consumer (D2C) and Reseller / Distribution model. Its website geistlich.com draws about 50 thousand monthly visits. Geistlich Pharma offers products and services including Geistlich Bio-Oss, Geistlich Bio-Gide, Chondro-Gide, Geistlich TauroSept, and Geistlich Derma-Gide. Its focus areas include Medical Devices, Dental Biomaterials and Orthopedic Biomaterials. Its legal entity is Geistlich Pharma AG.
Company details
Geistlich Pharma is recognized as a global leader in regenerative dentistry and orthopedics. The company is focused on developing and distributing biomaterials for bone and soft tissue regeneration in dental treatments, cartilage repair in orthopedic applications, and infection control in infectiology. Solutions are provided across multiple sectors including dental, orthopedic, and advanced wound care. Products such as Geistlich Bio-Oss and Chondro-Gide are utilized by professionals worldwide to improve patient outcomes. The company is committed to setting industry standards through innovative and proven regenerative solutions.
- Headquarters Wolhusen, Switzerland
- SectorsHealthcare
- Phone•••• ••••
- Website geistlich.com
- Legal Name Geistlich Pharma Ag
- Net Profit-$70.21 (USD)as on Sep 30, 2014
- Latest Funding Round$404.8K (USD), Grant
Apr 2019
- Investors
Products & Services of Geistlich Pharma
Geistlich Pharma offers a comprehensive portfolio of products and services, including Geistlich Bio-Oss, Geistlich Bio-Gide, Chondro-Gide, Geistlich TauroSept, and Geistlich Derma-Gide.
Bone substitute used for dental regeneration procedures.
Membrane used for guided tissue regeneration applications.
Matrix used for cartilage repair in orthopedics.
Product used for infection control in infectiology.
Material designed to support advanced wound healing.
Funding Insights of Geistlich Pharma
- Total Rounds 1
- Last Round Grant — $404,797
- First Round $404,797
(Apr 2019)
- Investors Count 1
All 1 funding rounds of Geistlich Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2019 | $404,797 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Geistlich Pharma
Geistlich Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Geistlich Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Geistlich Pharma
2 dated milestones of Geistlich Pharma across 168 years, from founding to its latest funding, stage changes and deals.
- Founded Geistlich Pharma is founded.
- Funding First funding round of $405K.
Web traffic of Geistlich Pharma
The website of Geistlich Pharma (geistlich.com) receives about 49.7K visits a month.
- Monthly visits49.7K
▲ 17.7% vs previous month
Websites whose visitors overlap most with Geistlich Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bioss.it | 100% | 1.1K | View details | ||
| biopharm.de | 100% | View details | |||
| starrett.com | 42% | 108.2K | #277,131 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Geistlich Pharma
Geistlich Pharma was founded in 1851 and raised its 1st funding round 168 years after it was founded.
Geistlich Pharma is headquartered in Wolhusen, Switzerland. It is registered at Wolhusen, Luzern, Switzerland.
Geistlich Pharma is recognized as a global leader in regenerative dentistry and orthopedics. The company is focused on developing and distributing biomaterials for bone and soft tissue regeneration in dental treatments, cartilage repair in orthopedic applications, and infection control in infectiology. Solutions are provided across multiple sectors including dental, orthopedic, and advanced wound care. Products such as Geistlich Bio-Oss and Chondro-Gide are utilized by professionals worldwide to improve patient outcomes. The company is committed to setting industry standards through innovative and proven regenerative solutions.
Geistlich Pharma offers Geistlich Bio-Oss, Geistlich Bio-Gide, Chondro-Gide, Geistlich TauroSept, and Geistlich Derma-Gide.
Geistlich Pharma has 1 investor. Key investors include European Union.
Geistlich Pharma operates through Geistlich Pharma Ag.